Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI solutions for neurovascular pathologies offered through the Sectra Amplifier Marketplace, which is a platform for contracting, purchasing and servicing artificial intelligence (AI) applications validated and verified for use at point of care.
Avicenna’s CINA solutions use deep learning to identify, detect and quantify life-threatening pathologies from computed tomography (CT) medical images. The US Food and Drug Administration (FDA)-cleared and CE-marked tools are seamlessly integrated within the clinical workflow, automatically triggering and reporting algorithm results through the systems already used by radiologists, an Avicenna press release states.
The AI tools to be included in Sectra’s Amplifier Marketplace include CINA-ICH and CINA-LVO, both of which are approved in the USA and European Union (EU), and CINA-ASPECTS, which is available in the EU only.
CINA-ICH uses deep learning to identify suspected intracranial haemorrhage (ICH) and prioritises those cases in the worklist, dramatically reducing turnaround time for head trauma and stroke patients. CINA-LVO is a triage tool for rapid automatic large vessel occlusion (LVO) detection, and real-time triage and prioritisation, accelerating clinical workflow and helping stroke teams in their diagnosis. CINA-ASPECTS is an AI-based automatic quantification tool that enables faster, more consistent, and more precise interpretation for the assessment of acute ischaemic stroke.
“To help healthcare providers get on the AI adoption journey, we have created the Sectra Amplifier Marketplace. We aim to facilitate easier access and usage of AI applications in medical imaging. This distribution agreement is an example of that. With Avicenna.AI tools deeply embedded in the Sectra diagnostic workspace, we provide our radiologists with enhanced diagnostic confidence for stroke cases,” said Nynke Breimer, global product manager, AI Radiology, Sectra.
“We provide best-in-class AI triage tools that enable fast detection of the leading causes of stroke, leading to more efficient patient management. We are glad to collaborate with a global partner such as Sectra. Through this agreement, we can help more clinicians to facilitate stroke decision-making, ensuring a prompt therapeutic response and ultimately improving patient outcomes,” said Cyril Di Grandi, co-founder and CEO, Avicenna.AI.
